Saturday 26 July 2014

FDA Accredits New Combination Painkillers Designed to Discourage Abuse

The U.S. Food and Drug Administration (FDA) has accredited a latest combination pain pill from the maker of OxyContin that is designed to discourage abuse by painkiller addicts. Purdue Pharma's new drug Targiniq ER is an extended release tablet that blends oxycodone - the active ingredient in OxyContin - with the drug naloxone. FDA regulators accredited the drug for daily, round-the-clock pain that does not react to other medications. ...

via Medindia Health News More READ

No comments:

Post a Comment